Mimickers of Urothelial Carcinoma and the Approach to Differential Diagnosis
Abstract
:1. Introduction
2. Urothelial Papilloma (UP)
3. Inverted Urothelial Papilloma (IUP)
4. Nephrogenic Adenoma (NA)
5. Polypoid Cystitis (PC), Fibroepithelial polyp (FP), Prostatic Polyp (PP), and Verumontanum Cyst (VC)
6. Xantho-Granulomatous Inflammation (XI)
7. Bacillus Calmette-Guerin-Induced Inflammatory Reaction (BCGitis)
8. Schistosomiasis (SC)
9. Keratinizing Desquamative Squamous Metaplasia (KSM)
10. Post-Radiation Changes (PRC)
11. Vaginal-Type Squamous Metaplasia (VM)
12. Endocervicosis (EC)/Endometriosis (EM) (Müllerianosis)
13. Malakoplakia (MK)
14. Florid von Brunn Nest Proliferation (VB), Cystitis Cystica (CC), and Cystitis Glandularis (CG)
15. IgG4-Related Disease (IGG4)
16. PEComa (PEC)
17. Pseudosarcomatous Myofibroblastic Proliferations
18. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Manini, C.; López, J.I. Unusual faces of bladder cancer. Cancers 2020, 12, 3706. [Google Scholar] [CrossRef]
- Epstein, J.I.; Amin, M.B.; Reuter, V.R.; Mostofi, F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 1998, 22, 1435–1448. [Google Scholar] [CrossRef] [PubMed]
- Al-Bashir, S.; Yilmaz, A.; Gotto, G.; Trpkov, K. Long term outcome of primary urothelial papilloma: A single institution cohort. Pathology 2014, 46, 37–40. [Google Scholar] [CrossRef]
- Bang, H.; Park, H.; Park, S.; Choi, E.; Cho, M.S.; Sung, S.H.; Choi, S.Y.; Cho, I.M.; Jeong, S.U.; Ro, J.Y. Clinicopathologic study of 60 cases of urothelial neoplasms with inverted growth patterns: Reclassification by international consultation on urologic disease (ICUD) recommendations. Ann. Diagn. Pathol. 2020, 44, 151433. [Google Scholar] [CrossRef]
- Picozzi, S.; Casellato, S.; Bozzini, G.; Ratti, D.; Macchi, A.; Rubino, B.; Pace, G.; Carmignani, L. Inverted papilloma of the bladder: A review and an analysis of the recent literature of 365 patients. Urol. Oncol. 2013, 31, 1584–1590. [Google Scholar] [CrossRef] [PubMed]
- Alexander, R.E.; Davidson, D.D.; Lopez-Beltran, A.; Montironi, R.; MacLennan, G.T.; Compérat, E.; Idrees, M.T.; Emerson, R.E.; Cheng, L. Human papillomavirus is not an etiologic agent of urothelial inverted papillomas. Am. J. Surg. Pathol. 2013, 37, 1223–1228. [Google Scholar] [CrossRef] [PubMed]
- Hodges, K.; Lopez-Beltran, A.; MacLennan, G.T.; Montironi, R.; Cheng, L. Urothelial lesions with inverted growth patterns: Histogenesis, molecular genetic findings, differential diagnosis and clinical management. BJU Int. 2010, 107, 532–537. [Google Scholar] [CrossRef]
- Patel, P.; Reikie, B.A.; Maxwell, J.P.; Yilmaz, A.; Gotto, G.T.; Trpkov, K. Long-term clinical outcome of inverted urothelial papilloma including cases with focal papillary pattern: Is continuous surveillance necessary? Urology 2013, 82, 857–860. [Google Scholar] [CrossRef]
- Kryvenko, O.N.; Epstein, J.I. Mimickers of urothelial neoplasia. Ann. Diagn. Pathol. 2019, 38, 11–19. [Google Scholar] [CrossRef]
- Santi, R.; Galli, I.C.; Canzonieri, V.; López, J.I.; Nesi, G. Inverted urothelial papilloma of the upper urinary tract: Description of two cases with systematic literature review. Diagn. Pathol. 2020, 15, 40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Akgul, M.; MacLennan, G.T.; Cheng, L. Distinct mutational landscape of inverted urothelial papilloma. J. Pathol. 2019, 249, 3–5. [Google Scholar] [CrossRef] [Green Version]
- Almassi, N.; Pietzak, E.J.; Sarungbam, J.; Tickoo, S.K.; Reuter, V.E.; Solit, D.B.; Al-Ahmadie, H.A. Inverted urothelial papilloma and urothelial carcinoma with inverted growth are histologically and molecularly distinct entities. J. Pathol. 2020, 250, 464–465. [Google Scholar] [CrossRef] [PubMed]
- McDaniel, A.S.; Zhai, Y.; Cho, K.R.; Dhanasekaran, S.M.; Montgomery, J.S.; Palapattu, G.; Siddiqui, J.; Morgan, T.; Alva, A.; Weizer, A.; et al. HRAS mutations are frequent in inverted urothelial neoplasms. Hum. Pathol. 2014, 45, 1957–1965. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Isharwal, S.; Hu, W.; Sarungbam, J.; Chen, Y.B.; Gopalan, A.; Fine, S.W.; Tickoo, S.K.; Sirintrapun, S.J.; Jadallah, S.; Loo, F.L.; et al. Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder. J. Pathol. 2019, 248, 260–265. [Google Scholar] [CrossRef]
- Mazal, P.R.; Schaufler, R.; Altenhuber-Müller, R.; Haitel, A.; Watschinger, B.; Kratzik, C.; Krupitza, G.; Regele, H.; Meisl, F.T.; Zechner, O.; et al. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients. N. Eng. J. Med. 2002, 347, 653–659. [Google Scholar] [CrossRef]
- López, J.I.; Schiavo-Lena, M.; Corominas-Cishek, A.; Yagüe, A.; Bauleth, K.; Guarch, R.; Hes, O.; Tardanico, R. Nephrogenic adenoma of the urinary tract: Clinical, histological, and immunohistochemical characteristics. Virchows Arch. 2013, 463, 819–825. [Google Scholar] [CrossRef] [PubMed]
- Santi, R.; Angulo, J.C.; Nesi, G.; de Petris, G.; Kuroda, N.; Hes, O.; López, J.I. Common and uncommon features of nephrogenic adenoma revisited. Pathol. Res. Pract. 2019, 215, 152561. [Google Scholar] [CrossRef]
- Sharifai, N.; Abro, B.; Chen, J.F.; Zhao, M.; He, H.; Cao, D. Napsin A is a highly sensitive marker for nephrogenic adenoma: An immunohistochemical study with a specificity test in genitourinary tumors. Hum. Pathol. 2020, 102, 23–32. [Google Scholar] [CrossRef]
- Kwok, J.L.; Eng, M. Polypoid cystitis and bilateral hydronephrosis mimicking urothelial carcinoma. J. Endourol. Case Rep. 2019, 5, 34–38. [Google Scholar] [CrossRef] [PubMed]
- Al-Ahmadie, H.; Gomez, A.M.; Trane, N.; Bove, K.E. Giant botryoid fibroepithelial polyp of bladder with myofibroblastic stroma and cystitis cystica et glandularis. Pediatr. Dev. Pathol. 2003, 6, 179–181. [Google Scholar] [CrossRef]
- Humphrey, P.A. Prostatic-type epithelial polyp of the urethra. J. Urol. 2015, 193, 2095–2096. [Google Scholar] [CrossRef]
- Nork, J.J.; Yap, M.K.; Kaplan, G.W. Verumontanum cyst associated with lower urinary tract symptoms in an adolescent. Urology 2016, 88, 192–194. [Google Scholar] [CrossRef]
- Korkes, F.; Favoretto, R.L.; Bróglio, M.; Silva, C.A.; Castro, M.G.; Perez, M.D. Xanthogranulomatous pyelonephritis: Clinical experience with 41 cases. Urology 2008, 71, 178–180. [Google Scholar] [CrossRef] [PubMed]
- Rodgers, S.A.; Williamson, S.R. Xanthogranulomatous ureteritis mimicking ureteral involvement by cancer in a radical cystectomy specimen. Int. J. Surg. Pathol. 2020. [Google Scholar] [CrossRef] [PubMed]
- Bates, A.W.; Fegan, A.W.; Baithun, S.I. Xanthogranulomatous cystitis associated with malignant neoplasms of the bladder. Histopathology 1998, 33, 212–215. [Google Scholar] [CrossRef]
- Ali, A.M.; Nelvigi, G.G.; Keshavaiah, V.G.; Ratkal, C.S. Extensive xanthogranulomatous cystitis mimicking bladder cancer. Urol. Ann. 2014, 6, 373–375. [Google Scholar] [CrossRef]
- Wang, Y.; Han, X.C.; Zheng, L.Q.; Miao, W.L. Xanthogranulomatous cystitis imitating bladder neoplasm: A case report and review of the literature. Int. J. Clin. Exp. Pathol. 2014, 7, 8255–8258. [Google Scholar]
- Jacobsen, A.; Joensen, U.N.; Hammershøj Jensen, P. A case of xanthogranulomatous inflammation of the urethra: Treatment with a steroid-based non-surgical approach. Scand. J. Urol. 2019, 53, 267–268. [Google Scholar] [CrossRef]
- Yeow, Y.; Chong, Y.L. Xanthogranulomatous pyelonephritis presenting as Proteus preperitoneal abscess. J. Surg. Case Rep. 2016, 2016, rjw211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Val-Bernal, J.F.; Castro, F. Xanthogranulomatous pyelonephritis associated with transitional cell carcinoma of the renal pelvis. Urol. Int. 1996, 57, 240–245. [Google Scholar] [CrossRef] [PubMed]
- Li, R.; Gilbert, S.M.; Kamat, A.M. Unraveling the mechanism of the antitumor activity of Bacillus Calmette-Guerin. Eur. Urol. 2020. [Google Scholar] [CrossRef] [PubMed]
- Colley, D.G.; Bustinduy, A.L.; Secor, W.E.; King, C.H. Human schistosomiasis. Lancet 2014, 383, 2253–2264. [Google Scholar] [CrossRef]
- Mbanefo, E.C.; Fu, C.L.; Ho, C.P.; Le, L.; Ishida, K.; Hammam, O.; Hsieh, M.H. Interleukin-4 signaling plays a major role in urogenital schistosomiasis-associated bladder pathogenesis. Infect. Immun. 2020, 88, e00669-19. [Google Scholar] [CrossRef] [PubMed]
- Ahmad, I.; Barnetson, R.J.; Krishna, N.S. Keratinizing squamous metaplasia of the bladder: A review. Urol. Int. 2008, 81, 247–251. [Google Scholar] [CrossRef] [PubMed]
- Boswell, P.D.; Fugitt, B.; Kane, C.J. Keratinizing desquamative squamous metaplasia of the kidney mimicking transitional cell carcinoma. Urology 1998, 52, 512–513. [Google Scholar] [CrossRef]
- Fitzpatrick, R.; Reynolds, L.F.; Watterson, J.D.; Lavallée, L.T.; Flood, T.A. Recurrent nephrolithiasis associated with keratinizing desquamative squamous metaplasia. Can. J. Urol. 2016, 23, 8577–8580. [Google Scholar]
- Coode-Bate, J.; Davies, M.C.; Cook, I. Keratinizing desquamative squamous metaplasia in the kidney of a patient with complex spinal cord injury. J. Spinal Cord Med. 2016, 39, 240–242. [Google Scholar] [CrossRef] [Green Version]
- Angulo, J.C.; López, J.I.; Flores, N. Pseudosarcomatous myofibroblastic proliferation of the bladder: Report of two cases and literature review. J. Urol. 1994, 151, 1008–1012. [Google Scholar] [CrossRef]
- Baker, P.M.; Young, R.H. Radiation-induced pseudocarcinomatous proliferations of the urinary bladder: A report of 4 cases. Hum. Pathol. 2000, 31, 678–683. [Google Scholar] [CrossRef]
- Long, E.D.; Shepherd, R.T. The incidence and significance of vaginal metaplasia of the bladder trigone in adult women. Br. J. Urol. 1983, 55, 189–194. [Google Scholar] [CrossRef]
- Henry, L.; Fox, M. Histological findings in pseudomembranous trigonitis. J. Clin. Pathol. 1971, 24, 605–608. [Google Scholar] [CrossRef] [PubMed]
- Stephenson, T.J.; Henry, L.; Harris, S.C.; Giri, D.D.; Fox, M.; Underwood, J.C.E. Pseudomembranous trigonitis of the bladder: Hormonal aetiology. J. Clin. Pathol. 1989, 42, 922–926. [Google Scholar] [CrossRef] [Green Version]
- Rogers, S.; Cross, S.S.; Williams, J.L.; Shortland, J.R. Vaginal metaplasia of the urothelium in two non-oestrogenized males. Histopathology 1991, 19, 378–379. [Google Scholar] [CrossRef]
- López, J.I.; Angulo, J.C. Vaginal metaplasia of the bladder associated with ectopic ureterocele. A clinicopathologic study of two cases. Arch. Anat. Cytol. Pathol. 1992, 40, 217–219. [Google Scholar]
- Habiba, M.; Brosens, I.; Benagiano, G. Müllerianosis, endocervicosis, and endosalpingiosis of the urinary tract: A literature review. Reprod. Sci. 2018, 25, 1607–1618. [Google Scholar] [CrossRef]
- Leonardi, M.; Espada, M.; Kho, R.M.; Magrina, J.F.; Millischer, A.E.; Savelli, L.; Condous, G. Endometriosis and the urinary tract: From diagnosis to surgical treatment. Diagnostics 2020, 10, 771. [Google Scholar] [CrossRef]
- Nakaguro, M.; Tsuzuki, T.; Shimada, S.; Taki, T.; Tsuchiyama, M.; Kitamura, A.; Suzuki, Y.; Nakano, Y.; Ono, K. Adenocarcinoma arising in urinary bladder endocervicosis. Pathol. Int. 2016, 66, 108–113. [Google Scholar] [CrossRef] [Green Version]
- Clement, P.B.; Young, R.H. Endocervicosis of the urinary bladder. A report of six cases of a benign müllerian lesion that may mimic adenocarcinoma. Am. J. Surg. Pathol. 1992, 16, 533–542. [Google Scholar] [CrossRef] [PubMed]
- Humphrey, P.A. Endometriosis, endocervicosis and müllerianosis of the bladder. J. Urol. 2014, 192, 1523–1524. [Google Scholar] [CrossRef] [PubMed]
- Hao, H.; Tsujimoto, M.; Tsubamoto, H.; Komori, S.; Hirota, S. Immunohistochemical phenotype of the urinary bladder endocervicosis: Comparison with normal endocervix and well-differentiated mucinous adenocarcinoma of the uterine cervix. Pathol. Int. 2010, 60, 528–532. [Google Scholar] [CrossRef]
- Sulman, A.; Goldman, H. Malacoplakia presenting as a large bladder mass. Urology 2002, 60, 163. [Google Scholar] [CrossRef]
- Lee, S.L.J.; Teo, J.K.; Limj, S.K.T.; Hema, P.S.; Mancer, K. Coexistence of malakoplakia and papillary urothelial carcinoma of the urinary bladder. Int. J. Surg. Pathol. 2015, 23, 575–578. [Google Scholar] [CrossRef] [PubMed]
- Zhong, M.; Tian, W.; Zhuge, J.; Zheng, X.; Huang, T.; Cai, D.; Zhang, D.; Yang, X.J.; Argani, P.; Fallon, J.T.; et al. Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. Am. J. Surg. Pathol. 2015, 39, 127–131. [Google Scholar] [CrossRef] [PubMed]
- Stone, J.H. What do the IgG4-related disease (IgG4-RD) classification criteria tell us about the nature of IgG4-RD? Presse Med. 2020, 49, 104020. [Google Scholar] [CrossRef]
- Park, H.G.; Kim, K.M. IgG4-related inflammatory pseudotumor of the renal pelvis involving renal parenchyma, mimicking malignancy. Diagn. Pathol. 2016, 11, 12. [Google Scholar] [CrossRef] [Green Version]
- Lei, W.; Xin, J.; Shao, C.; Mao, M.; Zhu, C.; Wu, C.; Jin, L. IgG4-related kidney disease mimicking malignant ureter tumor. Case report and literature review. Medicine (Baltimore) 2016, 95, e2550. [Google Scholar] [CrossRef]
- Zhong, W.; Kam, J.; Beattle, K.; Yuminaga, Y.; Ferguson, R.; Ko, R. A rare case of ureteral IgG4 disease masquerading as urothelial carcinoma. Urology 2018, 118, e1–e2. [Google Scholar] [CrossRef] [PubMed]
- Kufukihara, R.; Niwa, N.; Mizuno, R.; Ohara, K.; Mikami, S.; Kikuchi, E.; Oya, M. Immunoglobulin G4-related disease arising from the bladder wall. Urol. Int. 2019, 103, 488–490. [Google Scholar] [CrossRef]
- Jiang, Y.; Hou, G.; Cheng, W. Renal pelvis involvement of immunoglobulin G4-related disease mimicking malignancy on 18F-FDG PET/CT. Clin. Nucl. Med. 2019, 44, 767–768. [Google Scholar] [CrossRef]
- Gehring, C.; Starkebaum, G.A.; Voelzke, B.B.; Liew, J.W. Immunoglobulin G4-related disease of the urinary bladder. Rheumatology (Oxford) 2020, 59, 907–908. [Google Scholar] [CrossRef]
- Kamo, M.; Nozaki, T.; Muraishi, N.; Hattori, K.; Suzuki, K.; Okada, M.; Yamamura, J. CT findings of upper urinary tract lesions in IgG4-related disease: Comparison with urothelial carcinoma. AJR Am. J. Roentgenol. 2020, 215, 406–412. [Google Scholar] [CrossRef]
- Deshpande, V. The pathology of IgG4-related disease: Critical issues and challenges. Semin. Diagn. Pathol. 2012, 29, 191–196. [Google Scholar] [CrossRef]
- Martignoni, G.; Pea, M.; Reghellin, D.; Zamboni, G.; Bonetti, F. Perivascular epithelioid cell tumor (PEComa) in the genitourinary tract. Adv. Anat. Pathol. 2007, 14, 36–41. [Google Scholar] [CrossRef] [Green Version]
- Planelles, M.; Macías, L.; Peiró, G.; Bulimbasic, S.; Hes, O.; Robles, A.; Michal, M.; Davidson, W.; López, J.I. Rheb/mTOR/p70s6k cascade and TFE3 expression in conventional and sclerosing PEComas of the urinary tract. Appl. Immunohistochem. Mol. Morphol. 2016, 24, 514–520. [Google Scholar] [CrossRef] [PubMed]
- Pan, C.C.; Cheng, M.Y.; Ng, K.F.; Liu, C.Y.; Wang, J.S.; Chai, C.I.; Huang, S.H.; Chen, P.C.H.; Ho, D.M.T. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): Genetic evidence for the relationship of PEComa with angiomyolipoma. J. Pathol. 2008, 214, 387–393. [Google Scholar] [CrossRef]
- Hornick, J.L.; Fletcher, C.D.M. Sclerosing PEComa: Clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum. Am. J. Surg. Pathol. 2008, 32, 493–501. [Google Scholar] [CrossRef] [PubMed]
- Williamson, S.R.; Bunde, P.J.; Montironi, R.; López-Beltrán, A.; Zhang, S.; Wang, M.; MacLennan, G.T.; Cheng, L. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: Clinicopathologic, immunohistochemical and molecular features. Am. J. Surg. Pathol. 2013, 37, 1619–1626. [Google Scholar] [CrossRef] [PubMed]
- Alquati, S.; Gira, F.A.; Bartoli, V.; Contini, S.; Corradi, D. Low-grade myofibroblastic proliferations of the urinary bladder. Arch. Pathol. Lab. Med. 2013, 137, 1117–1128. [Google Scholar] [CrossRef] [PubMed]
- Angulo, J.C.; Santana, A.; Sanchez-Chapado, M. Bilateral keratinizing desquamative squamous metaplasia of the upper urinary tract. J. Urol. 1997, 158, 1908–1909. [Google Scholar] [CrossRef]
- Inamdar, A.A.; Pulinthanathu, R. Malignant transformation of inflammatory myofibroblastic tumor of urinary bladder: A rare case scenario. Bladder 2019, 6, e39. [Google Scholar] [CrossRef] [Green Version]
- Proppe, K.H.; Scully, R.E.; Rosai, J. Postoperative spindle cell nodules of genitourinary tract resembling sarcomas: A report of eight cases. Am. J. Surg. Pathol. 1984, 8, 101–108. [Google Scholar] [CrossRef] [PubMed]
- Nochomovitz, L.E.; Orenstein, J.M. Inflammatory pseudotumor of the urinary bladder–possible relationship to nodular fasciitis: Two case reports, cytologic observations, and ultrastructural observations. Am. J. Surg. Pathol. 1985, 9, 366–373. [Google Scholar] [CrossRef] [PubMed]
- Sebastin, J.A.S.; Smith, S.C.; Perry, K.D.; Gupta, N.S.; Alanee, S.; Carskadon, S.; Chitale, D.A.; Palanisamy, N.; Williamson, S.R. Pseudosarcomatous myofibroblastic proliferations of the genitourinary tract are genetically different from nodular fasciitis and lack USP6, ROS1 and ETV6 gene rearrangements. Histopathology 2018, 73, 321–326. [Google Scholar] [CrossRef] [PubMed]
- Acosta, A.M.; Demicco, E.G.; Dal Cin, P.; Hirsch, M.S.; Fletcher, C.D.M.; Jo, V.Y. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions. Mod. Pathol. 2020. [Google Scholar] [CrossRef]
- Bertz, S.; Stöhr, R.; Gaisa, N.T.; Wullich, B.; Hartmann, A.; Agaimy, A. TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder. Histopathology 2020, 77, 949–962. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Manini, C.; Angulo, J.C.; López, J.I. Mimickers of Urothelial Carcinoma and the Approach to Differential Diagnosis. Clin. Pract. 2021, 11, 110-123. https://doi.org/10.3390/clinpract11010017
Manini C, Angulo JC, López JI. Mimickers of Urothelial Carcinoma and the Approach to Differential Diagnosis. Clinics and Practice. 2021; 11(1):110-123. https://doi.org/10.3390/clinpract11010017
Chicago/Turabian StyleManini, Claudia, Javier C. Angulo, and José I. López. 2021. "Mimickers of Urothelial Carcinoma and the Approach to Differential Diagnosis" Clinics and Practice 11, no. 1: 110-123. https://doi.org/10.3390/clinpract11010017
APA StyleManini, C., Angulo, J. C., & López, J. I. (2021). Mimickers of Urothelial Carcinoma and the Approach to Differential Diagnosis. Clinics and Practice, 11(1), 110-123. https://doi.org/10.3390/clinpract11010017